The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Different Freezing Time in the Diffuse Parenchymal Lung Diseases
- Conditions
- Diagnostic YieldTransbronchial CryobiopsyFreezing TimeSafety
- Interventions
- Procedure: Transbronchial Cryobiopsy
- Registration Number
- NCT03927235
- Lead Sponsor
- Guangzhou Institute of Respiratory Disease
- Brief Summary
Transbronchial cryobiopsy in different freezing time is performed in patients with undefined diffuse parenchymal lung diseases, and assess the diagnostic yield and safety.
- Detailed Description
Transbronchial cryobiopsy in different freezing time is performed in patients with undefined diffuse parenchymal lung diseases, and assess the diagnostic yield and safety. This is a prospective randomized control trial.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- The patients are admitted in the institution as DPLD, while undefined after thorough history collection, laboratory examination and radiological data.
- Transbronchial cryobiopsy(TBCB) is indicated by clinicians for definitive diagnosis and patients are content with the examination with agreement signed.
- Blood gas analysis, routine blood test, ECG examination, coagulation function, immunological examination, chest HRCT, and liver/kidney function test have been completed.
- The radiological data indicates non-DPLD
- The clinical examinations mentioned above are not completed.
- The patient cannot endure or does not agree the procedure.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description the freezing time of 5s Transbronchial Cryobiopsy Transbronchial cryobiopsy in the freezing time of 5s the freezing time of 3s Transbronchial Cryobiopsy Transbronchial cryobiopsy in the freezing time of 3s the freezing time of 6s Transbronchial Cryobiopsy Transbronchial cryobiopsy in the freezing time of 6s the freezing time of 4s Transbronchial Cryobiopsy Transbronchial cryobiopsy in the freezing time of 4s
- Primary Outcome Measures
Name Time Method Diagnotic yield two weeks Percentage of definitive pathological diagnosis by transbronchial cryobiopsy, the alteration of original diagnosis after transbronchial cryobiopsy
- Secondary Outcome Measures
Name Time Method Complication rate one week Incidence of bleeding, pneumothorax (during the procedure and within 7 days after the intervention) and exacerbations of DPLD related to the transbronchial cryobiopsy
Trial Locations
- Locations (1)
the First Affiliated Hospital of Guangzhou Medical University
🇨🇳Guangzhou, Guangdong, China